Doctor profile · Federal record
Dr. HANNAH HOWARD, M.D.
Dermatology Physician (CMS: DERMATOLOGY) · TULSA, OK
- NPI 1902293020
- Accepts Medicare
- MIPS 93.3 / 100 · 2023
- 11 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
9245 S MINGO RD
TULSA, OK 741335793
(918) 492-8980 - Mailing address
-
1145 S UTICA AVE STE 100
TULSA, OK 741044000
Credentials & registration
- NPI registered
- April 2015 — 11 yrs on file
- Profile last updated
- July 16, 2019
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Oklahoma #31452
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1902293020. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,721
Distinct HCPCS
10
Medicare allowed
$276,504
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,724 | 302 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 652 | 471 | $85 | |
17000 |
Destruction of precancer skin growth, 1 growth | 515 | 401 | $48 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 306 | 211 | $120 | |
11102 |
Biopsy of related skin growth, first growth | 305 | 262 | $87 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 286 | 286 | $104 | |
17110 |
Destruction of skin growth, 1-14 growths | 175 | 156 | $99 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 148 | 26 | $1 | |
11103 |
Biopsy of related skin growth, each additional growth | 142 | 99 | $46 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 132 | 132 | $155 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 240. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$864
Transactions
32
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 8 | $328.16 | |
| E.R. Squibb & Sons, L.L.C. | 14 | $241.43 | |
| UCB, Inc. | 1 | $111.91 | |
| Amgen Inc. | 3 | $60.44 | |
| Dermavant Sciences, Inc. | 2 | $33.40 | |
| Janssen Biotech, Inc. | 1 | $29.41 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $23.95 | |
| Galderma Laboratories, L.P. | 1 | $20.28 | |
| PFIZER INC. | 1 | $14.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,028
Patients
574
Total drug cost
$470,880
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 151 | 87 | $2,791 |
| Clobetasol Propionate | Generic | 149 | 94 | $11,443 |
| Doxycycline Hyclate | Generic | 117 | 45 | $3,404 |
| Triamcinolone Acetonide | Generic | 113 | 90 | $1,153 |
| Fluorouracil | Generic | 112 | 95 | $11,560 |
| Fluocinonide | Generic | 62 | 42 | $3,473 |
| Otezla (Apremilast) | Brand | 51 | 0 | $243,955 |
| Clindamycin Phosphate | Generic | 44 | 29 | $1,861 |
| Mupirocin | Generic | 44 | 38 | $467 |
| Dupixent Pen (Dupilumab) | Brand | 43 | 0 | $181,482 |